Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2003 1
2004 4
2005 5
2006 3
2007 6
2008 1
2009 2
2010 3
2011 6
2012 5
2013 3
2014 6
2015 3
2016 2
2018 3
2019 1
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.
Stevens LE, Peluffo G, Qiu X, Temko D, Fassl A, Li Z, Trinh A, Seehawer M, Jovanović B, Alečković M, Wilde CM, Geck RC, Shu S, Kingston NL, Harper NW, Almendro V, Pyke AL, Egri SB, Papanastasiou M, Clement K, Zhou N, Walker S, Salas J, Park SY, Frank DA, Meissner A, Jaffe JD, Sicinski P, Toker A, Michor F, Long HW, Overmoyer BA, Polyak K. Stevens LE, et al. Among authors: almendro v. Cancer Res. 2023 Jan 18;83(2):264-284. doi: 10.1158/0008-5472.CAN-22-0423. Cancer Res. 2023. PMID: 36409824 Free PMC article.
Inhibitors of angiogenesis.
Almendro V, Gascón P. Almendro V, et al. Clin Transl Oncol. 2006 Jul;8(7):475-81. doi: 10.1007/s12094-006-0047-3. Clin Transl Oncol. 2006. PMID: 16870537 Review.
Cellular heterogeneity and molecular evolution in cancer.
Almendro V, Marusyk A, Polyak K. Almendro V, et al. Annu Rev Pathol. 2013 Jan 24;8:277-302. doi: 10.1146/annurev-pathol-020712-163923. Epub 2012 Oct 22. Annu Rev Pathol. 2013. PMID: 23092187 Review.
The neuronal influence on tumor progression.
Mancino M, Ametller E, Gascón P, Almendro V. Mancino M, et al. Among authors: almendro v. Biochim Biophys Acta. 2011 Dec;1816(2):105-18. doi: 10.1016/j.bbcan.2011.04.005. Epub 2011 May 14. Biochim Biophys Acta. 2011. PMID: 21616127 Free article. Review.
Intra-tumour heterogeneity: a looking glass for cancer?
Marusyk A, Almendro V, Polyak K. Marusyk A, et al. Among authors: almendro v. Nat Rev Cancer. 2012 Apr 19;12(5):323-34. doi: 10.1038/nrc3261. Nat Rev Cancer. 2012. PMID: 22513401 Review.
The pharmacological treatment of cachexia.
Argilés JM, Almendro V, Busquets S, López-Soriano FJ. Argilés JM, et al. Among authors: almendro v. Curr Drug Targets. 2004 Apr;5(3):265-77. doi: 10.2174/1389450043490505. Curr Drug Targets. 2004. PMID: 15058312 Review.
Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors.
Rye IH, Trinh A, Saetersdal AB, Nebdal D, Lingjaerde OC, Almendro V, Polyak K, Børresen-Dale AL, Helland Å, Markowetz F, Russnes HG. Rye IH, et al. Among authors: almendro v. Mol Oncol. 2018 Nov;12(11):1838-1855. doi: 10.1002/1878-0261.12375. Epub 2018 Sep 21. Mol Oncol. 2018. PMID: 30133130 Free PMC article.
56 results